Filed: 11/14/2024ACC: 0001104659-24-118950
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $1.91B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$1.91B
Total AUM (reported)
150.14M
Total Shares
Allocation by class
COM$1.72B90.1%
COM NEW$132.86M7.0%
COM SHS$18.09M0.9%
SPONSORED ADS$15.50M0.8%
CLASS A ORD SHS$8.21M0.4%
CL A ORD SHS$7.51M0.4%
ORD SHS$6.08M0.3%
Portfolio Concentration
Top 3$712.76M37.3%
4–10$539.80M28.3%
11–25$545.81M28.6%
Rest$110.88M5.8%
Top 3 weight
37.3%
Top 10 weight
65.6%
Voting Authority Distribution
Total shares with voting rights: 150.14M
Sole
Full voting authority
150.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$498.90M
26.13%
Sole
8.49M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$111.03M
5.82%
Sole
12.76M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$102.83M
5.39%
Sole
4.03M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$88.33M
4.63%
Sole
3.88M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares9.82M
TypeSH
Market value$83.51M
4.37%
Sole
9.82M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$78.98M
4.14%
Sole
2.69M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$78.09M
4.09%
Sole
2.17M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares3.09M
TypeSH
Market value$75.63M
3.96%
Sole
3.09M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.25M
TypeSH
Market value$72.37M
3.79%
Sole
6.25M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.40M
TypeSH
Market value$62.89M
3.29%
Sole
3.40M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.68M
TypeSH
Market value$61.39M
3.22%
Sole
5.68M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$47.76M
2.50%
Sole
1.74M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares4.40M
TypeSH
Market value$47.56M
2.49%
Sole
4.40M
Shared
0.00
None
0.00
MERUS N V
SOLEShares907.96K
TypeSH
Market value$45.36M
2.38%
Sole
907.96K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.39M
TypeSH
Market value$45.04M
2.36%
Sole
4.39M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares16.22M
TypeSH
Market value$44.27M
2.32%
Sole
16.22M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares706.13K
TypeSH
Market value$40.63M
2.13%
Sole
706.13K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares3.46M
TypeSH
Market value$38.08M
1.99%
Sole
3.46M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.41M
TypeSH
Market value$28.44M
1.49%
Sole
3.41M
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares5.56M
TypeSH
Market value$27.67M
1.45%
Sole
5.56M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$26.69M
1.40%
Sole
1M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.61M
TypeSH
Market value$24.87M
1.30%
Sole
1.61M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares3.57M
TypeSH
Market value$23.53M
1.23%
Sole
3.57M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$23.10M
1.21%
Sole
1.38M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares11.33M
TypeSH
Market value$21.41M
1.12%
Sole
11.33M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $498.90M 26.13% | 8.49M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $111.03M 5.82% | 12.76M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $102.83M 5.39% | 4.03M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $88.33M 4.63% | 3.88M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 9.82M | SH | $83.51M 4.37% | 9.82M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $78.98M 4.14% | 2.69M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $78.09M 4.09% | 2.17M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 3.09M | SH | $75.63M 3.96% | 3.09M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.25M | SH | $72.37M 3.79% | 6.25M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.40M | SH | $62.89M 3.29% | 3.40M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.68M | SH | $61.39M 3.22% | 5.68M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.74M | SH | $47.76M 2.50% | 1.74M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 4.40M | SH | $47.56M 2.49% | 4.40M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 907.96K | SH | $45.36M 2.38% | 907.96K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.39M | SH | $45.04M 2.36% | 4.39M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 16.22M | SH | $44.27M 2.32% | 16.22M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 706.13K | SH | $40.63M 2.13% | 706.13K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 3.46M | SH | $38.08M 1.99% | 3.46M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.41M | SH | $28.44M 1.49% | 3.41M | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 5.56M | SH | $27.67M 1.45% | 5.56M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 1M | SH | $26.69M 1.40% | 1M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.61M | SH | $24.87M 1.30% | 1.61M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 3.57M | SH | $23.53M 1.23% | 3.57M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $23.10M 1.21% | 1.38M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 11.33M | SH | $21.41M 1.12% | 11.33M | 0.00 | 0.00 |
Page 1 of 2